Investigation of Hyfrecators and Their In Vitro Interference with Implantable Cardiac Devices

被引:13
|
作者
Weyer, Christopher [1 ]
Siegle, Ronald J. [2 ,3 ]
Girard, Guillaume [4 ]
机构
[1] Cleveland Clin Fdn, Dept Dermatol, Plast Surg Inst, Cleveland, OH 44195 USA
[2] Ctr Surg Dermatol, Westerville, OH USA
[3] Ohio State Univ, Div Dermatol, Columbus, OH 43210 USA
[4] Medtronic Inc, Cardiac Rhythm Management, Mounds View, MN USA
关键词
DERMATOLOGICAL SURGERY;
D O I
10.1111/j.1524-4725.2012.02526.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BACKGROUND Guidelines exist for minimizing potential electromagnetic interference (EMI) with electrosurgical equipment in patients with cardiac rhythm management (CRM) devices. These guidelines encompass all electrosurgical devices but are not specific for hyfrecators. OBJECTIVE To investigate the potential interference of CRM devices by hyfrecators. MATERIALS AND METHODS Using a collagen-based saline gel, three implantable pulse generators (pacemakers) and three implantable cardioverter defibrillators were tested to measure the EMI from two commonly used hyfrecators. The six devices were tested using the hyfrecator under normal use settings and on maximum power. RESULTS Hyfrecators did not interfere with defibrillators and affected pacemakers only when used in close proximity to the device. For the pacemakers, atrial inhibition was observed at a distance of 3 cm on maximum hyfrecator settings and 1 cm at normal use settings. Ventricular inhibition occurred in very close proximity to the device (<1 cm) or in direct contact. CONCLUSION Hyfrecators are safe to use in patients with defibrillators and can be used in pacemaker patients within 2 inches of the device perimeter.
引用
收藏
页码:1843 / 1848
页数:6
相关论文
共 50 条
  • [41] Cardiac implantable electronic devices and cybersecurity
    Patel, Bhakti
    Makaryus, Amgad N.
    EXPERT REVIEW OF MEDICAL DEVICES, 2021, 18 (18) : 69 - 77
  • [42] Innovations in Cardiac Implantable Electronic Devices
    Khurrum Khan
    Jitae A. Kim
    Andra Gurgu
    Muzamil Khawaja
    Dragos Cozma
    Mihail G. Chelu
    Cardiovascular Drugs and Therapy, 2022, 36 : 763 - 775
  • [43] Infections of cardiac implantable electrical devices
    Billick, Maxime J.
    Bogler, Orly
    Gold, Wayne L.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2024, 196 (12) : E415 - E415
  • [44] Cybersecurity in cardiac implantable electronic devices
    Martignani, Cristian
    EXPERT REVIEW OF MEDICAL DEVICES, 2019, 16 (06) : 437 - 444
  • [45] MRI and implantable cardiac electronic devices
    Jung, Werner
    Jaeckle, Sebastian
    Zvereva, Vlada
    CURRENT OPINION IN CARDIOLOGY, 2015, 30 (01) : 65 - 73
  • [46] Safety of implantable cardiac devices - Reply
    Eagle, KA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (07): : 840 - 840
  • [47] Detection of cardiac tachyarrhythmias in implantable devices
    Gillberg, Jeffrey
    JOURNAL OF ELECTROCARDIOLOGY, 2007, 40 (06) : S123 - S128
  • [48] Future of implantable electrical cardiac devices
    Daubert, Jean-Claude
    Behaghel, Albin
    Leclercq, Christophe
    Mabo, Philippe
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2014, 198 (03): : 473 - 487
  • [49] MANAGEMENT OF INFECTED IMPLANTABLE CARDIAC DEVICES
    Bernard, K.
    Branscombe, P.
    Harper, H.
    Martin, P.
    Methot, M.
    CANADIAN JOURNAL OF CARDIOLOGY, 2010, 26 : 164D - 164D
  • [50] Extraction of implantable cardiac electronic devices
    Rickard J.
    Wilkoff B.L.
    Current Cardiology Reports, 2011, 13 (5) : 407 - 414